Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giorgio Bogani, Innocenza Palaia, Giorgia Perniola, Federica Tomao, Antonella Giancotti, Daniele Di Mascio, Giuseppe Capalbo, Ludovico Muzii, Pierluigi Benedetti Panici & Violante Di Donato. (2023) An update on current pharmacotherapy for vulvar cancer. Expert Opinion on Pharmacotherapy 24:1, pages 95-103.
Read now
Read now
Articles from other publishers (16)
Peter L. Stern. (2023) Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?. Tumour Virus Research 16, pages 200263.
Crossref
Crossref
Jeffrey M. Skolnik & Matthew P. Morrow. (2023) Vaccines for HPV-associated diseases. Molecular Aspects of Medicine 94, pages 101224.
Crossref
Crossref
Claire Buchta Rosean, Erica C. Leyder, Jeneice Hamilton, Joseph J. Carter, Denise A. Galloway, David M. Koelle, Paul Nghiem & Teri Heiland. (2023) LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition. Frontiers in Immunology 14.
Crossref
Crossref
Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari & Ronen Borenstein. (2023) Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications. Cancers 15:14, pages 3692.
Crossref
Crossref
Xiangjin Gong, Hao Chi, Zhijia Xia, Guanhu Yang & Gang Tian. (2023) Advances in HPV‐associated tumor management: Therapeutic strategies and emerging insights. Journal of Medical Virology 95:7.
Crossref
Crossref
Liba Sokolovska, Maria Isaguliants & Franco M. Buonaguro. (2023) Proceedings of the Online Conference “Vaccines and Vaccination during and Post COVID Pandemics” (7–9 December 2022). Vaccines 11:7, pages 1175.
Crossref
Crossref
Charles JN. Lacey. (2023) Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers. Tumour Virus Research 15, pages 200250.
Crossref
Crossref
Ojone Illah & Adeola Olaitan. (2023) Updates on HPV Vaccination. Diagnostics 13:2, pages 243.
Crossref
Crossref
John T. Schiller, Lauri E. Markowitz, Aimée R. Kreimer & Douglas R. Lowy. 2023. Plotkin's Vaccines. Plotkin's Vaccines
484
513.e11
.
Jay A. Berzofsky, Purevdorj B. Olkhanud & Hoyoung M. Maeng. 2023. Plotkin's Vaccines. Plotkin's Vaccines
191
210.e9
.
Janice García-Quiroz, Bismarck Vázquez-Almazán, Rocío García-Becerra, Lorenza Díaz & Euclides Avila. (2022) The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics. Cells 11:16, pages 2528.
Crossref
Crossref
Seyed Mohammad Miri, Behzad Pourhossein, Seyed Younes Hosseini, Mohsen Keshavarz, Shohreh Shahmahmoodi, Mohammad Reza Zolfaghari, Seyed Reza Mohebbi, Ali Gorji & Amir Ghaemi. (2022) Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade. Virology Journal 19:1.
Crossref
Crossref
Young Hun Chung, Derek Church, Edward C. Koellhoffer, Elizabeth Osota, Sourabh Shukla, Edward P. Rybicki, Jonathan K. Pokorski & Nicole F. Steinmetz. (2021) Integrating plant molecular farming and materials research for next-generation vaccines. Nature Reviews Materials 7:5, pages 372-388.
Crossref
Crossref
Supitcha Kamolratanakul & Punnee Pitisuttithum. (2021) Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines 9:12, pages 1413.
Crossref
Crossref
Ditte Rahbæk Boilesen, Karen Nørgaard Nielsen & Peter Johannes Holst. (2021) Novel Antigenic Targets of HPV Therapeutic Vaccines. Vaccines 9:11, pages 1262.
Crossref
Crossref
Mira Hoteit, Zeina Oneissi, Ranim Reda, Fadi Wakim, Amar Zaidan, Mohammad Farran, Eli Abi‑Khalil & Mirvat El‑Sibai. (2021) Cancer immunotherapy: A comprehensive appraisal of its modes of application (Review). Oncology Letters 22:3.
Crossref
Crossref